GlassScriptPhysician profile
Manuel Antonio Villa Sanchez
NPI 1891942454
$18,473.32
in general payments reported to CMS, 2019-2025
7 companies · $131 in 2025
The $131 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,130 · 2020: $4,053 · 2021: $764 · 2022: $713 · 2023: $4,624 · 2024: $1,058 · 2025: $131.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $3,000 · Travel and Lodging: $2,496 · Food and Beverage: $317.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $3,000.00 |
| Travel and Lodging | $2,495.71 |
| Food and Beverage | $316.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Covidien LP | $11,130.16 | 2019-2020 | |
| Intuitive Surgical, INC. | $5,595.77 | 2020-2024 | Ion, Da Vinci Surgical System |
| Steris Corporation | $809.17 | 2024 | |
| Zimmer Biomet Holdings, INC. | $759.49 | 2023-2024 | Advantagerib |
| Abbott Laboratories | $130.88 | 2025 | Aveir |
| Veran Medical Technologies, INC. | $28.57 | 2020 | |
| La Jolla Pharmaceutical Company | $19.28 | 2023 | Giapreza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Manuel Villa Sanchez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.